Zoetis | ZTS - Equity Capital And Reserves

Stock Price
116.44
Daily Change
-1.43 -1.21%
Monthly
0.09%
Yearly
-25.09%
Q2 Forecast
114.37

Zoetis reported $3.33B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Align Technology USD 3.96B 44.68M Sep/2025
Bayer EUR 25.95B 3.75B Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Coherus Biosciences USD 61.01M 26.76M Dec/2025
Dentsply International USD 1.34B 139M Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Henry Schein USD 3.24B 116M Dec/2025
Idexx Laboratories USD 1.61B 44.2M Dec/2025
Illumina USD 2.72B 342M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
J&J USD 81.19B 358M Mar/2026
Laboratory Of America USD 8.62B 93.2M Dec/2025
Merck USD 51.85B 2.79B Sep/2025
Neogen USD 2.1B 2.09M Dec/2025
Pacira USD 693.11M 34.1M Dec/2025
Perrigo USD 2.94B 1.51B Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Quest Diagnostics USD 7.37B 196M Mar/2026
Sanofi EUR 72.81B 1.1B Mar/2026
Sanofi EUR 71.71B 14.25B Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025